Background and purpose: Central 5-HT-containing pathways are known to be important in cardiovascular regulation and a crucial area for this regulation is the nucleus tractus solitarius (NTS), which contains many of the known 5-HT receptor subtypes. In this study the role of 5-HT 1B and 5-HT 1D receptors, targets for the antimigraine drugs known collectively as triptans, was examined in the NTS. Experiment approach: Extracellular recordings were made, in anaesthetized rats, from 109 NTS neurones that were excited by electrical stimulation of the vagus and drugs were applied ionophoretically to these neurones. Key results: The 5-HT 1B/1D receptor agonist sumatriptan applied to 64 neurones produced a 64% reduction in the firing rate of 54 of these neurones. Ketanserin, a 5-HT 1D/2A receptor antagonist, alone had little effect, but co-applied with sumatriptan significantly attenuated this inhibition, whilst co-application of the 5-HT 1B receptor antagonist GR55562 resulted in potentiation of this inhibition. Sumatriptan also caused a 25% reduction in vagal afferent evoked activity as well as that caused by stimulation of cardiopulmonary afferents. In another 41 neurones the 5-HT 1B receptor agonist CP-93 129 produced a doubling of the background firing rate in 31 of these neurones and a significant increase in both vagal afferent evoked activity and that evoked by cardiopulmonary afferent activation. Conclusions and implications: Activation of 5-HT 1B and 5-HT 1D receptors have opposing actions on NTS neurones of excitation and inhibition, respectively. As both receptors are negatively coupled to adenylate cyclase this would indicate that they have different anatomical locations within NTS.
Introduction
Central 5-HT 1A , 5-HT 3 and 5-HT 7 receptors have been demonstrated to play a major role in the reflex regulation of the cardiovascular system (see Ramage, 2001; Jordan, 2005; Kellett et al., 2005a) . Furthermore, depletion of central 5-HT causes an increase in resting blood pressure and attenuates the baroreceptor gain (Kellett et al., 2005b) . One of the major brain sites involved in the regulation of the cardiovascular system is the nucleus tractus solitarius (NTS) (see Jordan and Spyer, 1986 ). This nucleus has been shown to contain many of the 14 identified 5-HT receptor subtypes: 5-HT 1A and 5-HT 1B (Manaker and Verderame, 1990; Thor et al., 1992; Castro et al., 1997; Longmore et al., 1997) , 5-HT 1D (Longmore et al., 1997) , 5-HT 1F (Castro et al., 1997) , 5-HT 2A and 5-HT 2C (Pompeiano et al., 1994) , (Leslie et al., 1994; Miquel et al., 2002) , 5-HT 5A (Oliver et al., 2000) and 5-HT 7 receptors (Gustafson et al., 1996) . At present, there is evidence suggesting that 5-HT 3 (Jeggo et al., 2005) and 5-HT 7 (Kellett et al., 2004) , but probably not 5-HT 1A (Ramage and Mifflin, 1998) , receptors in the NTS participate in the reflex pathways controlling cardiovascular reflexes. Furthermore, 5-HT 2A/B and 5-HT 2C receptors have also been found to affect NTS neurone activity and have opposing actions, excitation and inhibition, respectively (Sévoz-Couche et al., 2000) . However, central blockade of 5-HT 2 receptors does not seem to interfere with cardiovascular (Bogle et al., 1990) or airway (Bootle et al., 1996 (Bootle et al., , 1998 reflexes mediated by the NTS. In addition, activation of central 5-HT 2 receptors by DOI failed to affect airway reflexes (Bootle et al., 1998) . Interestingly, the archetypical 5-HT 1B/1D receptor agonist and antimigraine drug sumatriptan, acting centrally, has been shown to inhibit these cardiovascular (Dando et al., 1998) and airway (Bootle et al., 1998) reflexes. Thus, the present study was carried out to investigate the effects of 5-HT 1B and 5-HT 1D receptor agonists on neuronal activity in the NTS. Preliminary accounts of some of this work have been published (Wang et al., 1998; Jeggo et al., 2000) .
Methods
Experiments were performed on 27 male Sprague-Dawley rats (280-350 g body weight) anaesthetized with pentobarbitone sodium (initially 60 mg kg
À1
, intraperitoneal (i.p.), supplemented when necessary with 10 mg kg À1 , intravenous (i.v.) The rats were fixed in a stereotaxic frame and the right cervical vagus nerve was dissected free from the sympathetic trunk low in the neck using a dorsolateral approach. The nerve was then placed on bipolar silver wire electrodes for electrical stimulation (50-500 mA, 1 ms, 0.3-1 Hz) by an isolated stimulator (Digitimer DS2A) that was triggered by a programmer (Digitimer 4030). The exposed length of nerve was covered in paraffin wax and fixed in place with dental impression material (Super-Dent light body dental polyvinylsiloxane). To expose the dorsal surface of the caudal brainstem, the nuchal muscles were removed from the back of the neck, the occipital bone removed and the dura overlying the brainstem cut and reflected laterally. In some cases, during single-cell recordings, the animals were immobilized by administration of a neuromuscular blocker, either decamethonium bromide (3 mg kg À1 , i.v.; initial dose followed by 3 mg kg À1 h
, i.v.) or a single dose of a-bungarotoxin (140 mg kg À1 , i.v.). The depth of anaesthesia was assessed during neuromuscular blockade by monitoring the stability of the arterial blood pressure and heart rate and the cardiovascular responses to pinching the paw.
Protocol
Extracellular recordings were made from neurones in the medial regions of the NTS (o1 mm lateral to midline) within 2 mm caudal to obex using five or seven barrelled microelectrodes made from borosilicate glass (Clarke Electromedical, Reading, UK) or compound electrodes constructed by gluing a single-barrelled glass recording electrode (tip diameter 1 mm) to a multibarrelled glass electrode (tip diameter 3-7 mm, Wang et al., 1998) . The recording barrel contained NaCl (0.5-4 M), whereas the other barrels contained pontamine sky blue dye, the excitant amino acid DL-homocysteic acid (DLH) and a combination of ligands for 5-HT 1B/1D -receptors. Neuronal recordings were amplified Â 1000-Â 5000 (Axoclamp 2A, Axon Instruments, CA, USA) and filtered (0.5-5.0 kHz; NL 125, Neurolog). NTS neurones were identified by their orthodromic response to electrical stimulation of the cervical vagus nerve at 2 Â threshold for evoking activity (Wang et al., 1995; Jeggo et al., 2005) . NTS neurones receiving non-myelinated vagal input mediate a diverse range of functions. In the present study, one functional subpopulation of these neurones was identified by their response to cardiopulmonary afferent stimulation induced by right atrial administration of PBG (12-24 mg kg À1 , 60-120 ml kg
À1
; Kay and Armstrong, 1990) . Ligands were applied to the vicinity of the recorded neurones by ionophoresis (Neurophore, Medical Systems, Digitimer Ltd). Between drug ejection periods a retaining current of 10-15 nA was applied to each drug barrel. When neuronal firing rate was steady, the effects of agonist and/or antagonist ligands given alone or in combination were tested. In all experiments, any possible current artefacts were minimized by using the automatic current balancing device available on the Neurophore system. In some experiments, recording sites were marked by ionophoretic ejection of pontamine sky blue dye. At the end of the experiment, the brainstem was removed and fixed in 10% formal saline. Frozen sections (50 mm) were cut and the location of the recording sites visualized and mapped onto standard sections of a rat brainstem (Paxinos and Watson, 1986 ).
Analysis of data
Arterial blood pressure, tracheal pressure, ECG and neuronal activity were recorded on videotape via a digital interface (Instrutech, VR100A, Digitimer Ltd) and/or on a PC hard disk accessed via an A-D interface (Cambridge Electronic Design (CED 1401plus, Science Park, Milton Road, Cambridge, UK). Off-line analysis of recorded data was made using Spike2 software (CED). Single unit activity was discriminated using a Spike Processor (D130, Digitimer Ltd) and displayed as a rate histogram. To investigate the effects of ligands on ongoing NTS neuronal activity, baseline and ligand-evoked neuronal firing rates (averaged over a 10-20 s period) were measured and compared. Peri-stimulus time histograms (PSTHs, 20 stimuli) were constructed to investigate the effect of ligands on the vagal-evoked response of NTS neurones. The total numbers of evoked spikes before and during ionophoretic application of the ligands were compared. The response of NTS neurones to cardiopulmonary afferent stimulation by PBG injected into the right atrium was analysed by counting the total number of spikes evoked from the beginning of the excitatory burst until activity returned to pre-injection level. Ligands were classed as evoking excitation or inhibition if activity increased or decreased, respectively, by more than 20% (Wang et al., 1995; Jeggo et al., 2005) . All data are presented as mean7s.e.m. except where indicated. Comparisons between means were made with Student's paired t-test.
Drugs and solutions
The following drugs were freshly dissolved in 0.9% saline, except where stated, and their pH adjusted by addition of drops of either 0.1 M HCl or 0.1 M NaOH and administered by ionophoresis: DLH (100 mM, pH 8.5) from Sigma-Aldrich, Poole, Dorset; sumatriptan (20 mM, pH 4) was a gift from Glaxo SmithKline, Harlow; ketanserin (10 mM, pH 4), GR55562 (3-[3-(dimethylamino) propyl]-4-hydroxy-N-[4-(4-pyridinyl)phenyl]benzamide; 10 mM, pH 4) and CP-93 129 (1,4-dihydro-3-[1,2,3,6-tetrahydrp-4 -pyridinyl]-5H-pyrrol [3,2-b] pyridine-5-one dihydrochloride; 10 mM, pH 4) from Tocris Cookson Ltd. CP-93 129 was dissolved in 50 ml 1% ascorbic acid, then made up to 1 ml with 0.9% saline. Pontamine sky blue dye (20 mg ml
À1
; from BDH, Poole, Dorset) was dissolved in 0.5 M sodium acetate. The following drugs were also used; PBG and a-bungarotoxin, both from Sigma-Aldrich, Poole, Dorset.
Results
Identification of NTS neurones NTS neurones (n ¼ 102) were identified by their orthodromic excitatory responses to electrical stimulation of the cervical vagus nerve (50-500 mA, 1 ms, 0.3-1 Hz). The latency of this input ranged from 24 to 45 ms (mean 31.770.43 ms), indicating that the conduction velocity was within the C-fibre range (0.9-1.7 m s ), whereas a further seven neurones received short latency input alone (4-7 ms, mean 5.970.46 ms; conduction velocity range 5.7-10 m s À1 , mean 7.170.62 ms). In addition, 39 (38%) of those neurones receiving longer latency input had a very small variability in onset latency indicating that they are likely to include (but not exclusively) those receiving monosynaptic inputs, whereas the remainder of neurones (62%) with a greater variability of onset latency are more likely to be activated polysynaptically. Furthermore, 52 (51%) of all neurones recorded exhibited spontaneous activity (2.170.2 spikes s À1 ), a similar proportion to that seen in a previous study (Sévoz-Couche et al., 2000) . In experiments, where the effects of 5-HT 1B/1D receptor ligands were investigated, activity was in some cases induced by ionophoretic administration of low currents (2-15 nA) of the excitant amino acid DLH. ) and produced a non-significant decrease in activity in 50% (7/14) of neurones (4.871.8-2.570.8 spikes s À1 ). In only one neuron increased activity was seen (0.3-1.5 spikes s
À1
). However, during application of ketanserin, the inhibitory action of sumatriptan (4.170.8-1.270.3 spikes s
) was significantly attenuated (3.971.0-2.870.6 spikes s À1 ) in 78% (11/14) of neurones tested (Figure 2b ). Interestingly, in three of these 11 neurones the inhibition in baseline activity evoked by sumatriptan (2.270.4-1.170.2 spikes s À1 )
was reversed in the presence of ketanserin to a nonsignificant increase in activity (2.370.03-3.070.3 spikes s À1 , Figure 2a) .
Furthermore, in 55% (6/11) of neurones tested, the inhibitory effects of sumatriptan (6.972.0-2.970.8 spikes s
) were significantly increased in the presence of the 5-HT 1B receptor antagonist GR55562 (6.571.6-1.270.5 spikes s
; Figure 3 ) without any change in baseline activity. In the remaining neurones (45%; 5/11), the sumatriptan-evoked inhibition was unaffected by GR55562. GR55562 itself reduced baseline activity in one group of NTS neurones. In 63% (20/32) of neurones tested, activity decreased from 4.771.0 to 2.670.5 spikes s À1 , whereas in the remaining neurones (37%; 12/32) activity was unaffected (4.871.2 vs 4.370.9 spikes s
). In neurones that GR55562 had reduced baseline activity, activity was increased back to baseline level by applying DLH before repeating sumatriptan-evoked inhibition.
The 5-HT 1B receptor agonist CP-93 129 had a predominantly excitatory effect on NTS neurones. In 76% (31/41) of neurones tested, CP-93 129 (40-160 nA) evoked a significant ). The bars show when sumatriptan was being applied at the currents stated in the absence and presence of ketanserin. (b) Histograms of the combined data of NTS neuronal activity showing means with vertical lines representing s.e.m. From left to right: baseline activity (n ¼ 11), activity evoked by ionophoretic administration of sumatriptan (20-160 nA; n ¼ 11), recovery (n ¼ 11), baseline activity in the presence of ketanserin (10-40 nA; n ¼ 11), activity evoked by sumatriptan in the presence of ketanserin (10-40 nA; n ¼ 11) and recovery (n ¼ 5). Comparison of inhibition caused by sumatriptan alone and in the presence of ketanserin was carried out using Student's paired t-test. ) and the bottom depicts the raw extracellular recording of neuronal activity (cell). The bars show when sumatriptan was being applied at the currents stated in the absence and presence of GR55562. (b) Histograms of the combined data of NTS neuronal activity showing means with vertical lines representing s.e.mean. From left to right: baseline activity (n ¼ 6), activity evoked by ionophoretic administration of sumatriptan (20-160 nA; n ¼ 6), recovery (n ¼ 6), baseline activity in the presence of GR55562 (10-80; n ¼ 6), activity evoked by sumatriptan in the presence of GR55562 (10-80 nA; n ¼ 6) and recovery (n ¼ 4). Comparison of inhibition caused by sumatriptan alone and in the presence of GR55562 was carried out using Student's paired t-test. The combined data from 28 neurones that were excited whereas (ii) represents the combined data from five neurones that showed inhibition. Comparisons were carried out using Student's paired t-test. ). Although the differences in the mean baseline activity of these groups could indicate different populations of neurones, in actual fact neurones with background activity similar to and indeed higher than the activity of neurones in the inhibitory responding group can be found in the excitatory responding group.
Ionophoretic administration of saline at pH 4 (the vehicle for sumatriptan, ketanserin and GR55562) had no significant effect in 92% (11/12) of neurones tested (8.272.8-8.272.8 spikes s À1 ), with only one neurone showing an increase in activity of 420%. Similarly, 1% ascorbic acid at pH 4 (the vehicle for CP-93 129) had no significant effect on the baseline firing rate of the majority of neurones tested (5/6; 2.170.8-2.270.8 spikes s À1 ) with the activity of the only affected neurone being reduced. Figure 5 ). In addition, it decreased cardiopulmonary afferent input ( Figure 6 ) in two of the three neurones tested, the input of the remaining neurone being unaffected by sumatriptan. In contrast, ionophoretic application of CP-93 129 increased vagal afferent evoked activity (27.674.3-36.774 .6 spikes 20sweeps
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À1
) in 88% (22/25) of neurones tested ( Figure 5 ) and increased the cardiopulmonary afferent (Figure 6 ) evoked input (4.771. 3-16.074 .0 spikes) in 60% (3/5) of neurones, with the input of the remaining two neurones unaffected.
Discussion
The results for the present experiments demonstrate that in anaesthetized rats the activity of NTS neurones receiving input from vagal afferents is reduced by ionophoretic application of the 5-HT 1B/1D receptor ligand sumatriptan, which has a pK D at the r5-HT 1B receptor of 6.74 and at 5-HT 1D receptors of 7.95 (Bruinvels et al., 1993) . Conversely, ionophoretic administration of the selective 5-HT 1B receptor agonist CP-93 129 (Macor et al., 1990) , which has a pK D at 5-HT 1D receptors of 8.2 compared with 6.2 at the r5-HT 1B (Bruinvels et al., 1993) increased the activity of these neurones. Further, in the presence of ketanserin, which is a highly selective 5-HT 1D receptor antagonist (pK i of 7) compared with pK i of o5 at the h5-HT 1B receptor (Kaumann et al., 1994) , the inhibitory effects of sumatriptan were found to be reduced and in some cases reversed. It should be noted that ketanserin is also a 5-HT 2A (Bonhaus et al., 1995) , an a 1 -adrenoceptor and a H 1 receptor antagonist (Leysen et al., 1985) . These data support the view that sumatriptan causes inhibition of neuronal activity by activating 5-HT 1D receptors and that this inhibitory effect is counteracted by the activation of excitatory 5-HT 1B receptors by sumatriptan. This interpretation is further supported by the observation that in the presence of GR55562, a h5-HT 1B receptor antagonist (pK i of 8.8, whereas at 5-HT 1D receptors it has a pK i of 6.2; Longmore et al., 1997) , the sumatriptan-evoked inhibition was found to be potentiated in just over 50% of 
(2) Figure 6 Traces showing the effects of ionophoretically applied (1) sumatriptan and (2) CP-93 129 to the vicinity of a NTS neurone (in anaesthetized rats), that had been excited by cardiopulmonary afferent activation (induced by injecting PBG (18 mg kg
À1
; 30 ml) into the right atrium) on blood pressure (BP), continuous rate histogram of neuronal activity (spikes bin
) and a raw recording of neuronal activity. In (2) it should be noted that the background activity is vagal evoked activity (0.5 Hz) and demonstrates the stability of the recording of the neurone over time. Cell identity between panels is confirmed by the expanded sections.
the neurones tested. It should be noted that some of these effects of sumatriptan could also be mediated by activation of 5-HT 1F receptors (Adham et al., 1993) . However, at present, there are no available selective antagonists for this receptor subtype and thus this possibility cannot be investigated.
The ability of sumatriptan to inhibit baseline and the vagal activation of NTS neurones is consistent with observations that it attenuates cardiovascular (Dando et al., 1998) and airway (Bootle et al., 1998) reflexes that are mediated by vagal afferents. This can occur both centrally and at the level of sympathetic ganglia . Furthermore, the excitation of NTS neurones evoked by stimulation of Ad afferents from the superior sagittal sinus has also been found to be inhibited by the ionophoretic application of 5-HT 1B/1D receptor agonists (Hoskin et al., 2004) , as had previously been shown for trigeminal neurones (Storer and Goadsby, 1997) . The inhibition of trigeminal neurones is also mediated by 5-HT 1D receptors (Travagli and Williams, 1996; Jennings et al., 2004) . However, the physiological role of these receptors is not clear. Although ketanserin had a strong tendency to reduce ongoing activity this probably reflects an action at other receptor subtypes (see above) rather than 5-HT 1D receptors, especially as the present data suggest that blockade of tonically activated 5-HT 1D receptors induces excitation. Thus, overall the present antagonist data suggest that in the 'resting' state, at least in anaesthetized animals, these 5-HT 1D receptors in the NTS are not tonically activated. Thus, the question arises as to their physiological function. However, the selective 5-HT 1B/1D receptor antagonist GR127935 (Skingle et al., 1996) , given i.c., has been found to have a tendency to potentiate the cardiovascular responses evoked by stimulation of the upper airways (Dando et al., 1998) . This at least suggests that 5-HT 1D receptors may have some physiological role and the variable results observed with GR127935 would be consistent with its ability to block both receptor subtypes. This also indicates that 5-HT 1B receptors may receive a tonic input. However, further experiments need to be carried out to determine if these 5-HT receptor subtypes have a physiological role at the level of the NTS.
The present data, indicating that 5-HT 1B and 5-HT 1D receptors have opposing actions on NTS neurones, are somewhat surprising as both receptors inhibit cyclic AMP formation. This would suggest that within the NTS these receptors are not located at the same site. In this respect, 5-HT 1D receptors have been located on the central terminals of trigeminal primary afferents fibres of rat (Potrebic et al., 2003) and human (Smith et al., 2002) and on afferents in the human solitary tract and nucleus (Longmore et al., 1997) . Thus, if 5-HT 1D receptors are located on afferent terminals in the NTS, they would act to inhibit the release of glutamate, as indicated by the ability of non-NMDA glutamate antagonists to attenuate monosynaptic afferent excitation of NTS neurones (Zhang and Mifflin, 1988) , from such terminals. For 5-HT 1B receptors, the overall evidence indicates that they can act as auto-and heteroreceptors causing excitation or inhibition (see Sari, 2004) . As these receptors are negatively coupled to adenylate cyclase, it is likely that at the level of the NTS they inhibit a tonic inhibitory, presumably GABAergic, input onto these neurones similar to 5-HT 1B receptors in the substantia nigra (Stanford and Lacey, 1996) . Thus, they facilitate vagal input, as indicated in the present experiments.
In conclusion, the results from the present study demonstrate that yet another set of 5-HT receptors can influence activity of NTS neurones. However, the role that these receptors play in the control of cardiovascular and airway reflexes by central 5-HT-containing neurones remains to be determined. The present data also indicate that the administration of triptans to treat migraine could affect cardiovascular reflexes. Therefore, some of the unexpected cardiovascular effects observed with these drugs could be due to an action within the NTS.
